Clinical Trials Directory

Trials / Unknown

UnknownNCT05451680

Negative-pressure Wound Therapy on Full-thickness Skin Grafts of the Lower Leg

A Randomized Study on the Effect of Negative-pressure Wound Therapy on Below-the-knee Skin Cancer Graft Reconstruction Complications

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Helsinki University Central Hospital · Academic / Other
Sex
All
Age
18 Years – 110 Years
Healthy volunteers
Not accepted

Summary

This randomized controlled non-sponsored trial on 60 patients evaluates if a portable negative-pressure device improves graft-take and decrease the risk of surgical complications for skin-cancer surgeries below the knee.

Detailed description

Annually, 12 000 skin cancers are diagnosed in Finland. This randomized controlled non-sponsored trial evaluate if a portable negative-pressure device improves graft-take and decrease the risk of surgical complications. 60 patients over 18 years of age are included and randomly assigned to either the negative pressure-treatment group or the conventional treatment group. At the control appointment one-week postsurgery, graft take is documented as a primary outcome and any complications (necrosis, infection, hematoma/seroma) and adverse events (pain, skin reactions) as secondary outcomes. Adverse events are evaluated by a phone call 3 weeks postsurgery and based on medical records 3 months postsurgery.

Conditions

Interventions

TypeNameDescription
DEVICENegative pressure deviceNegative-pressure therapy postoperatively on the full-thickness skin graft
PROCEDUREConventional careConventional dressing postoperatively on the full-thickness skin graft

Timeline

Start date
2020-08-01
Primary completion
2024-01-01
Completion
2024-07-01
First posted
2022-07-11
Last updated
2023-11-21

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT05451680. Inclusion in this directory is not an endorsement.

Negative-pressure Wound Therapy on Full-thickness Skin Grafts of the Lower Leg (NCT05451680) · Clinical Trials Directory